Literature DB >> 12368363

Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.

Susanne Wirth1, Annelyse Vessaz, Claude Krummenacher, Frédéric Baribaud, Hans Acha-Orbea, Heidi Diggelmann.   

Abstract

To study the major histocompatibility complex class II I-E dependence of mouse mammary tumor virus (MMTV) superantigens, we constructed hybrids between the I-E-dependent MMTV(GR) and the I-E-independent mtv-7 superantigens and tested them in vivo. Our results suggest that, although the C-terminal third mediates I-A interaction, additional binding sites are located elsewhere in the superantigen.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12368363      PMCID： PMC136634          DOI： 10.1128/jvi.76.21.11172-11175.2002

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  11 in total

1.  Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis.

Authors:  P N Hsu; P Wolf Bryant; N Sutkowski; B McLellan; H L Ploegh; B T Huber
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

2.  Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.

Authors:  C W McMahon; B Traxler; M E Grigg; A M Pullen
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

Review 3.  Mouse mammary tumor virus: immunological interplays between virus and host.

Authors:  S A Luther; H Acha-Orbea
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

4.  Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells.

Authors:  H Acha-Orbea; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

5.  In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.

Authors:  C Krummenacher; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.

Authors:  F Baribaud; S Wirth; I Maillard; S Valsesia; H Acha-Orbea; H Diggelmann
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.

Authors:  B A Torres; N D Griggs; H M Johnson
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

8.  Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules.

Authors:  D G Mottershead; P N Hsu; R G Urban; J L Strominger; B T Huber
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

9.  Correcting an immune-response deficiency by creating E alpha gene transgenic mice.

Authors:  M Le Meur; P Gerlinger; C Benoist; D Mathis
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

Review 10.  Expression of the mouse mammary tumor virus ORF gene in cultured cells.

Authors:  K Blöchlinger; H Diggelmann
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311
View more
  2 in total

1.  Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice.

Authors:  Joy Loh; Guoyan Zhao; Christopher A Nelson; Penny Coder; Lindsay Droit; Scott A Handley; L Steven Johnson; Punit Vachharajani; Hilda Guzman; Robert B Tesh; David Wang; Daved H Fremont; Herbert W Virgin
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

2.  N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins.

Authors:  María Carla Rosales Gerpe; Tyler Milston Renner; Kasandra Bélanger; Cindy Lam; Halil Aydin; Marc-André Langlois
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.